Literature DB >> 33672561

Application of Environment-Friendly Rhamnolipids against Transmission of Enveloped Viruses Like SARS-CoV2.

Ling Jin1,2, Wendy Black1, Teresa Sawyer3.   

Abstract

In the face of new emerging respiratory viruses, such as SARS-CoV2, vaccines and drug therapies are not immediately available to curb the spread of infection. Non-pharmaceutical interventions, such as mask-wearing and social distance, can slow the transmission. However, both mask and social distance have not prevented the spread of respiratory viruses SARS-CoV2 within the US. There is an urgent need to develop an intervention that could reduce the spread of respiratory viruses. The key to preventing transmission is to eliminate the emission of SARS-CoV2 from an infected person and stop the virus from propagating in the human population. Rhamnolipids are environmentally friendly surfactants that are less toxic than the synthetic surfactants. In this study, rhamnolipid products, 222B, were investigated as disinfectants against enveloped viruses, such as bovine coronavirus and herpes simplex virus 1 (HSV-1). The 222B at 0.009% and 0.0045% completely inactivated 6 and 4 log PFU/mL of HSV-1 in 5-10 min, respectively. 222B at or below 0.005% is also biologically safe. Moreover, 50 μL of 222B at 0.005% on ~1 cm2 mask fabrics or plastic surface can inactivate ~103 PFU HSV-1 in 3-5 min. These results suggest that 222B coated on masks or plastic surface can reduce the emission of SARS-CoV2 from an infected person and stop the spread of SARS-CoV2.

Entities:  

Keywords:  222A; 222B; HSV-1; HSV-1-GFP; bovine coronavirus; coronavirus; rhamnolipids

Year:  2021        PMID: 33672561     DOI: 10.3390/v13020322

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  8 in total

Review 1.  Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19.

Authors:  Amita Daverey; Kasturi Dutta; Sanket Joshi; Achlesh Daverey
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 2.  Biosurfactants in the sustainable eradication of SARS COV-2 from the environmental surfaces.

Authors:  Zulfiqar Ali Raza; Qaisar Shahzad; Asma Rehman; Muhammad Taqi; Asif Ayub
Journal:  3 Biotech       Date:  2022-09-11       Impact factor: 2.893

3.  Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.

Authors:  Soheila Kazemi; Alberto Domingo López-Muñoz; Jaroslav Hollý; Ling Jin; Jonathan W Yewdell; Brian P Dolan
Journal:  J Virol       Date:  2022-08-24       Impact factor: 6.549

4.  Rhamnolipid Micellization and Adsorption Properties.

Authors:  Yi Zhang; Tess L Placek; Ruksana Jahan; Paschalis Alexandridis; Marina Tsianou
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

Review 5.  Recent Advances in Biomedical, Therapeutic and Pharmaceutical Applications of Microbial Surfactants.

Authors:  Chiara Ceresa; Letizia Fracchia; Emanuele Fedeli; Chiara Porta; Ibrahim M Banat
Journal:  Pharmaceutics       Date:  2021-03-30       Impact factor: 6.321

6.  Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses.

Authors:  Rosa Giugliano; Carmine Buonocore; Carla Zannella; Annalisa Chianese; Fortunato Palma Esposito; Pietro Tedesco; Anna De Filippis; Massimiliano Galdiero; Gianluigi Franci; Donatella de Pascale
Journal:  Pharmaceutics       Date:  2021-12-08       Impact factor: 6.321

7.  Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs.

Authors:  Soheila Kazemi; Alberto Domingo López-Muñoz; Jaroslav Hollý; Ling Jin; Jonathan W Yewdell; Brian P Dolan
Journal:  bioRxiv       Date:  2021-10-22

Review 8.  Antimicrobial Compounds from Microorganisms.

Authors:  Cynthia Amaning Danquah; Prince Amankwah Baffour Minkah; Isaiah Osei Duah Junior; Kofi Bonsu Amankwah; Samuel Owusu Somuah
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.